166 filings
Page 5 of 9
6-K
kk4z6d5gopgeaw si
9 Apr 19
Galmed Pharmaceuticals Announces Successful Completion of
8:10am
6-K
rrp dmrq3igfp6
4 Apr 19
Current report (foreign)
4:31pm
6-K
ykd2xx7
13 Mar 19
Galmed Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
7:23am
6-K
jwgice6am8visf2denm
12 Mar 19
Galmed Reports Positive Results from Pharmacokinetic
8:14am
6-K
9kuvain3jvp 8m2b9
26 Dec 18
Current report (foreign)
8:00am
6-K
1aqg29 s7t17380v3
14 Nov 18
Current report (foreign)
4:30pm
6-K
3nzzphhc24d 6w28k
5 Nov 18
Galmed Pharmaceuticals Provides Business Update and Reports Third Quarter 2018 Financial Results
7:00am
6-K
wn4t45k0fvwl4un
16 Oct 18
Current report (foreign)
4:30pm
6-K
tyog7j8qad6kqq8nmzl
30 Aug 18
Current report (foreign)
12:00am
6-K
bywmz hqzadpko8iuqm
2 Aug 18
Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2018 Financial Results
7:01am
6-K
o3nwuoda m1rq3uigai1
19 Jul 18
Current report (foreign)
5:21pm
6-K
yfx0z00f3 dh
21 Jun 18
Current report (foreign)
4:19pm
6-K
5vg3qloq8ymulzozz313
18 Jun 18
Current report (foreign)
6:35am
6-K
gzhnh73j
12 Jun 18
Galmed’s 600 mg AramcholTM Achieved a Regulatory Approvable Endpoint Showing NASH
7:00am
6-K
ny9176cw 04zb3977
9 May 18
Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2018 Financial Results
7:00am
6-K
a6mum 0qwf0mjtd7w57
4 Apr 18
Current report (foreign)
12:00am
6-K
lqv23 6n2aw
3 Apr 18
Galmed Pharmaceuticals Announces Pricing of $6.0 Million Registered Direct Offering
12:00am
6-K
hodxzzxqxm2 mqr7s
13 Mar 18
Galmed Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
12:00am
6-K
gjwjb4yv1r 72wu3u3h
14 Feb 18
Galmed Announces ARRIVE Study Data
12:00am
6-K
0jka6rd7366nlpio3jwj
7 Feb 18
Galmed Granted "Preferred Technological Enterprise" Status Which
12:00am